Cyberknife® hypofractionated stereotactic radiosurgery (CK-hSRS) as salvage treatment for brain metastases.
Sergej TelentschakDaniel RuessStefan GrauRoland GoldbrunnerNiklas von SpreckelsenKarolina JablonskaHarald TreuerMartin KocherMaximilian RugePublished in: Journal of cancer research and clinical oncology (2021)
Our radiation schedule showed a reasonable treatment effectiveness and tolerance. Representing an optimal salvage treatment for critical BM in patients with a very poor prognosis and clinical performance state, CK-hSRS may close the gap between surgery, stereotactic radiosurgery, conventional radiotherapy, and palliative care.
Keyphrases
- poor prognosis
- palliative care
- brain metastases
- small cell lung cancer
- radiation therapy
- randomized controlled trial
- systematic review
- early stage
- long non coding rna
- squamous cell carcinoma
- minimally invasive
- combination therapy
- coronary artery disease
- replacement therapy
- acute coronary syndrome
- advanced cancer
- protein kinase
- smoking cessation